Srx Health Solutions Inc (SRXH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,077 | -2,830 | N/A | -8,069 | -6,448 |
| Depreciation Amortization | 3,322 | 55 | N/A | 1,427 | 995 |
| Accounts receivable | -1,623 | 24 | N/A | -1,831 | 958 |
| Accounts payable and accrued liabilities | 5,181 | 550 | N/A | 4,875 | 1,261 |
| Other Working Capital | 5,433 | 1,045 | N/A | 5,462 | 3,055 |
| Other Operating Activity | -623 | 150 | 0 | -2,758 | -1,058 |
| Operating Cash Flow | $613 | $-1,006 | $N/A | $-894 | $-1,237 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,490 | -3 | N/A | -10 | -10 |
| Investing Cash Flow | $-4,490 | $-3 | $N/A | $-10 | $-10 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,562 | N/A | N/A | 9,556 | 4,164 |
| Debt Issued | 4,288 | N/A | N/A | N/A | 2,792 |
| Debt Repayment | -3,009 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 2,208 | 2,208 |
| Other Financing Activity | 0 | 430 | 0 | -16,533 | -13,783 |
| Financing Cash Flow | $3,841 | $430 | $N/A | $-4,769 | $-4,619 |
| Exchange Rate Effect | -1,546 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 2,070 | 4,455 | N/A | 9,473 | 9,473 |
| End Cash Position | 488 | 3,876 | N/A | 3,800 | 3,607 |
| Net Cash Flow | $-1,582 | $-579 | $N/A | $-5,673 | $-5,866 |
| Free Cash Flow | |||||
| Operating Cash Flow | 613 | -1,006 | N/A | -894 | -1,237 |
| Capital Expenditure | -4,490 | -3 | N/A | -10 | -10 |
| Free Cash Flow | -3,877 | -1,009 | 0 | -904 | -1,247 |